Method of detecting thrombotic disease risk

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2292764

Polymorphisms within a plasma carboxypeptidase designated plasma carboxypeptidase B (PCPB) have been identified. The relative distribution of these polymorphs in a patient's blood can be used to assess an indivudual's risk toward thrombotic disease.

L'invention concerne l'identification de polymorphismes à l'intérieur d'une plasma carboxypeptidase désignée sous le nom de plasma carboxypeptidase B (PCPB). La répartition relative de ces polymorphes dans le sang d'un patient peut permettre d'évaluer le risque d'affections thrombotiques chez un individu.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of detecting thrombotic disease risk does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of detecting thrombotic disease risk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting thrombotic disease risk will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1736241

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.